Supplements
NMN vs NR Supplements Compared: What the Evidence Actually Shows in 2026
A candid breakdown of top NAD+ booster brands reveals strong biomarker data but slim evidence for real longevity outcomes.
Revisione
23 mag 2026 0
Tutti gli articoli
86 articoli
Metabolic Health
Insulin Resistance in Aging Is a Whole-Body Failure, Not Just a Blood Sugar Problem
A new framework redefines age-related insulin resistance as a systemic collapse of metabolic resilience spanning muscle, fat, brain, and more.
Revisione
23 mag 2026 0
Autoimmune & Arthritis
CAR T Cell Therapy Could Reset the Immune System in Autoimmune Disease
A major review in Nature Medicine explores how CAR cell therapies may achieve deep immune 'reset' in autoimmune diseases by depleting pathogenic B cells.
Revisione
23 mag 2026 0
Gut & Microbiome
Why Vaccines Work Less in Older Adults and How to Fix That
Aging disrupts gut microbiota and mTOR signaling, crippling vaccine responses — but targeted interventions may reverse this.
Revisione
23 mag 2026 0
Supplements
NMN vs NR: Which NAD+ Supplement Actually Has the Evidence Behind It
A 2026 comparative review of leading NAD+ supplements reveals NR has stronger human data, while NMN marketing often outpaces clinical proof.
Revisione
21 mag 2026 0
Heart Health
Harvard Team Outlines Rigorous Framework for Evaluating Heart Devices With Real-World Data
A Circulation review from Harvard proposes the 'target trial framework' to improve how observational data is used to assess cardiovascular device safety and effectiveness.
Revisione
19 mag 2026 0
Gut & Microbiome
How Aging T Cells Destroy Your Gut Barrier and Fuel Chronic Inflammation
Age-related shifts in intestinal T cell populations may silently erode gut barrier function, accelerating the chronic inflammation that drives aging diseases.
Revisione
17 mag 2026 0
Supplements
NMN vs NR in 2026: Which NAD+ Precursor Actually Wins
Expert reviews compare NMN and NR head-to-head. NMN edges out for muscle and sleep benefits; NR leads for neuroprotection.
Revisione
15 mag 2026 0
Metabolic Health
GLP-1 Drugs and Metformin Trim BMI in Obese Youth but Long-Term Safety Remains Unknown
A Cochrane review of 37 RCTs finds obesity drugs modestly reduce weight in adolescents, but evidence quality is low and long-term data are absent.
Revisione
14 mag 2026 0
Cancer Research
Myeloid Cell Plasticity Emerges as a Key Target for Next-Gen Cancer Therapies
A new review reframes how myeloid cells fuel or fight tumors, pointing to plasticity — not just cell diversity — as the core therapeutic target.
Revisione
14 mag 2026 0
Heart Health
AHA Updates Secondary Prevention Guidelines After Bypass Surgery
The American Heart Association's 2026 update outlines evidence-based strategies to slow disease progression and protect grafts after CABG.
Revisione
14 mag 2026 0
Metabolic Health
CGM Devices for Biohackers Ranked by Evidence in 2026
A head-to-head review of 10 CGM devices for healthy adults, weighing real-world accuracy data against limited longevity evidence.
Revisione
13 mag 2026 0